QR Code

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

<p>Abstract</p> <p>Background</p> <p>The prognosis of pT1a-pT1b breast cancer (BC) used to be considered very good, with a 10-y RFS of 90%. However, some retrospective studies reported a 10-y RFS of 81%–86% and suggested benefit from adjuvant systemic therapy.</p> <p>Methods</p> <p>To evaluate the v...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Gori Stefania, Clavarezza Matteo, Siena Salvatore, Foglietta Jennifer, Tarenzi Emiliana, Giordano Monica, Molino Annamaria, Graiff Claudio, Fusco Vittorio, Alabiso Oscar, Baldini Editta, Gamucci Teresa, Altavilla Giuseppe, Dondi Davide, Venturini Marco
Hōputu: Artigo
Reo:Inglês
I whakaputaina: BMC 2012-04-01
Rangatū:BMC Cancer
Ngā marau:
pT1a and pT1b breast cancer
Adjuvant chemotherapy
Adjuvant hormonal therapy
Urunga tuihono:http://www.biomedcentral.com/1471-2407/12/158
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite